Codon 311 (Cys→Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias

被引:44
作者
Janka, Z
Juhász, A
Rimanóczy, A
Boda, K
Márki-Zay, J
Kálmán, J
机构
[1] Univ Szeged, Fac Med, Dept Psychiat, Albert Szent Gyorgyi Ctr Med & Pharmaceut Sci, H-6725 Szeged, Hungary
[2] Bekes Cty Hosp, Cent Lab, H-5701 Gyula, Hungary
关键词
paraoxonase; apolipoprotein E; genetic markers; Alzheimer's disease; vascular dementia; DNA polymorphism;
D O I
10.1038/sj/mp/4000916
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The gene of an esterase enzyme, called paraoxonase (PON, EC.3.1.8.1.) is a member of a multigene family that comprises three related genes PON1, PON2, and PON3 with structural homology clustering on the chromosome 7.(1,2) The POW activity and the polymorphism of the POW and PON2 genes have been found to be associated with risk of cardiovascular diseases such as hypercholesterolaemia, non-insulin-dependent diabetes, coronary heart disease (CHD) and myocardial infaction.(3-8) The importance of cardiovascular risk factors in the pathomechanism of Alzheimer's disease (AD) and vascular dementia (VD)(9-13) prompted us to examine the genetic effect of PON2 gene codon 311 (Cys-Ser; PON2*S) polymorphism and the relationship between the PON2*S allele and the other dementia risk factor, the apoE polymorphism in these dementias. The PON2*C and PON2*S allele frequencies were similar in both AD (25% and 75%) and VD groups (23% and 77%), respectively, compared with the controls (27% and 73%). The ratio of the PON2*S carriers was significantly higher among the apoE4 allele carrier AD (27%) and VD (25%) groups than in the control (12%). Our results indicate that the PON2*S and apoE4 alleles have interactive effect on the development of the two most common forms of dementias AD and VD, and further support the hypothesis that cardiovascular factors contribute to the development of AD.
引用
收藏
页码:110 / 112
页数:3
相关论文
共 25 条
[11]   Increased apolipoprotein E4 allele frequency is associated with vascular dementia in the Hungarian population [J].
Kalman, J ;
Juhasz, A ;
Csaszar, A ;
Kanka, A ;
Rimanoczy, A ;
Janka, Z ;
Rasko, I .
ACTA NEUROLOGICA SCANDINAVICA, 1998, 98 (03) :166-168
[12]   Apolipoprotein E allele frequencies in patients with late-onset sporadic Alzheimer's dementia in Hungary [J].
Kalman, J ;
Juhasz, A ;
Csaszar, A ;
Kanka, A ;
Magloczky, E ;
Bencsik, K ;
Janka, Z ;
Rasko, I .
ACTA NEUROLOGICA SCANDINAVICA, 1997, 95 (01) :56-59
[13]   Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus [J].
Mackness, B ;
Mackness, MI ;
Arrol, S ;
Turkie, W ;
Julier, K ;
Abuasha, B ;
Miller, JE ;
Boulton, AJM ;
Durrington, PN .
ATHEROSCLEROSIS, 1998, 139 (02) :341-349
[14]   SERUM PARAOXONASE ACTIVITY IN FAMILIAL HYPERCHOLESTEROLEMIA AND INSULIN-DEPENDENT DIABETES-MELLITUS [J].
MACKNESS, MI ;
HARTY, D ;
BHATNAGAR, D ;
WINOCOUR, PH ;
ARROL, S ;
ISHOLA, M ;
DURRINGTON, PN .
ATHEROSCLEROSIS, 1991, 86 (2-3) :193-199
[15]  
MCELVEEN J, 1986, CLIN CHEM, V32, P671
[16]   A SIMPLE SALTING OUT PROCEDURE FOR EXTRACTING DNA FROM HUMAN NUCLEATED CELLS [J].
MILLER, SA ;
DYKES, DD ;
POLESKY, HF .
NUCLEIC ACIDS RESEARCH, 1988, 16 (03) :1215-1215
[17]   The gln-arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients [J].
Ombres, D ;
Pannitteri, G ;
Montali, A ;
Candeloro, A ;
Seccareccia, F ;
Campagna, F ;
Cantini, R ;
Campa, PP ;
Ricci, G ;
Arca, M .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) :1611-1616
[18]   The human serum paraoxonase arylesterase gene (PON1) is one member of a multigene family [J].
PrimoParmo, SL ;
Sorenson, RC ;
Teiber, J ;
LaDu, BN .
GENOMICS, 1996, 33 (03) :498-507
[19]   The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease [J].
Rice, GI ;
Ossei-Gerning, N ;
Stickland, MH ;
Grant, PJ .
CORONARY ARTERY DISEASE, 1997, 8 (11-12) :677-682
[20]   GLN-ARG192 POLYMORPHISM OF PARAOXONASE AND CORONARY HEART-DISEASE IN TYPE-2 DIABETES [J].
RUIZ, J ;
BLANCHE, H ;
JAMES, RW ;
GARIN, MCB ;
VAISSE, C ;
CHARPENTIER, G ;
COHEN, N ;
MORABIA, A ;
PASSA, P ;
FROGUEL, P .
LANCET, 1995, 346 (8979) :869-872